Abstract
Introduction:
Suboptimal and differential participant engagement in randomized trials—including retention at primary outcome assessments and attendance at intervention sessions—undermines rigor, internal validity, and trial conclusions.
Methods:
First, this study describes the Methods-Motivational Interviewing approach and strategies for implementation. This approach engages potential participants before randomization via interactive, prerequisite orientation sessions that illustrate the scientific rationale behind trial methods in accessible language and use motivational interviewing to diffuse ambivalence about participation. Then, this study examines potential improvements in retention (proportion of participants assessed at follow-up visits) and attendance (e.g., mean percentage of intervention sessions attended, percentage of participants who attended 0 sessions) in 3 randomized weight-management trials that quickly added prerequisite orientations to their protocols following early signs of suboptimal or differential participant engagement (Supporting Health by Integrating Nutrition and Exercise [SHINE, 2009–2013, n=194]; Get Social [2016–2020, n=217]; GestationaL Weight Gain and Optimal Wellness [GLOW, 2014–2018, n=389]). Using a pre–post analytical design, adjusted estimates from regression models controlling for condition and assessment timepoint (analyses from 2020) are reported.
Results:
After adding prerequisite orientations, all 3 trials attained higher participant engagement. Retention at assessments was 11.4% and 17.3% higher (Get Social, SHINE). Mean percentage attendance at intervention sessions was 8.8% higher (GLOW) and 10.1% less participants attended 0 intervention sessions (Get Social). Descriptively, all remaining retention and attendance outcomes were consistently higher, but non-significant. Across trials, adding prerequisite orientations did not affect the proportion of eligible participants enrolled or baseline demographics.
Conclusions:
The Methods-Motivational Interviewing approach shows promise for increasing rigor of randomized trials and is readily adaptable to in-person, webinar, and conference call formats.
Trial Registration:
All 3 trials are registered at www.clinicaltrials.gov (SHINE: NCT00960414; Get Social: NCT02646618; GLOW: NCT02130232).
INTRODUCTION
Participant engagement in randomized behavioral intervention trials is typically assessed as participant retention at follow-up assessments of trial primary outcomes and participant attendance at behavioral intervention classes. Yet, suboptimal and/or differential trial retention and intervention attendance can distort the validity of trial conclusions, diminish rigor, and jeopardize investments made in the trial by investigators, funders, and participants themselves.
In 2005, Goldberg and Kiernan1 first described the innovative Methods-Motivational Interviewing (MMI) approach of prerequisite orientation sessions to increase retention in randomized trials. Prerequisite orientations—interactive and purposely held well before participants enroll—go beyond providing trial information. Rather, prerequisite orientations meaningfully involve participants in actively learning about the trial design and research question at hand, explain the scientific rationale behind trial methods, diffuse ambivalence about the pros/cons that participants generate when considering participation, and explicitly encourage potential participants to consider 2 commitments including to self (by changing target behaviors) and to the trial methods (by completing all trial assessments independently of personal success).
The MMI approach, including the interactive prerequisite orientations, was descriptively associated with high retention in 2 initial trials.1,2 The MMI approach and related strategies have since been integrated in numerous randomized behavioral intervention trials across a wide variety of health problems and populations including e-health programs for adults with unhealthy lifestyles,3,4 family-based programs promoting healthy lifestyles,5 self-management of type 1 diabetes for adolescents,6 healthy diets for asthma control among adults with uncontrolled asthma,7 faith-based programs,8 exercise programs for diverse and vulnerable populations such as sedentary Latino adults and family caregivers,9–11 digital cognitive behavioral therapy to reduce insomnia symptoms among pregnant women,12 in-person cognitive behavioral therapy for depression among patients with chronic pain,13 and others.14
The current study first describes MMI’s core constructs and key strategies. Then, using a pre–post analytic design, the study examines whether participant retention and attendance increased in 3 randomized weight management intervention trials that quickly added prerequisite orientations to their protocols in response to early signs of suboptimal or differential trial retention and intervention attendance. Finally, the study describes each trial’s innovative adaptations to the MMI approach.
METHODS
MMI Approach
Informed by community-based participatory research principles in which participants are considered partners,15 the MMI approach leverages interactive, prerequisite orientation sessions, held well before randomization, informed by 4 core constructs: set clear participant expectations (e.g., be transparent about lengthy assessments), explain the scientific rationale behind trial methods in easy-to-understand language (e.g., why randomize and impact of poor retention on trial conclusions), diffuse ambivalence about research participation using motivational interviewing (e.g., generate pros/cons of trial participation), and make 2 commitments explicit (to self and to trial methods). Ideally, the MMI approach should be implemented before a trial starts. Table 1 presents MMI’s core constructs and key strategies, as well as specific examples of the originally implemented procedures and adapted procedures in the 3 trials (e.g., online webinar/webchat, conference calls).
Table 1.
Methods-Motivational Interviewing Approach to Prerequisite Orientation Sessions: Core Constructs, Key Strategies, Originally Implemented Procedures, and Adapted Procedures
Core constructs | Key strategies | Originally implemented proceduresa | Adapted procedures (corresponding trial) |
---|---|---|---|
Set clear expectations for participants (e.g., trial staff are transparent about lengthy assessments) |
|
|
|
Explain the scientific principles behind trial methods (e.g., randomization and retention) |
|
|
|
Diffuse ambivalence about participating in research using motivational interviewing (e.g., trial staff remain neutral regarding participation) |
|
|
|
Make 2 commitments explicit (to self and to trial methods) |
|
|
None |
Goldberg JH, Kiernan M. Innovative techniques to address retention in a behavioral weight-loss trial. Health Educ Res 2005;20(4):439–447
Kiernan M, Oppezzo MA, Resnicow K, Alexander GL. Effects of a methodological infographic on research participants’ knowledge, transparency, and trust. Health Psychol. 2018;37(8):782–786.
SHINE, Supporting Health by Integrating Nutrition and Exercise; GLOW, GestationaL Weight Gain and Optimal Wellness.
Trial Characteristics
This analysis examined the impact of adding prerequisite orientations on retention and attendance across three randomized trials, each of which compared a multisession behavioral weight management program for adults with a control condition (Table 2). These trials were a convenience sample, selected because the MMI approach was implemented in ongoing trials (not before the start).
Table 2.
Characteristics of Trials and Prerequisite Orientation Sessions
Characteristics | SHINE | Get Social | GLOW |
---|---|---|---|
Trial characteristics | |||
Sample size for present analysis | N=194 | N=217 | N=389 |
Dates of data collection Population, location | 2009–2013 | 2016–2020 | 2014–2018 |
Adults with obesity (BMI 30–45 kg/m2) and elevated waist circumference (men, >102 cm; women, >88 cm); California | Adults with overweight or obesity (BMI 27–45 kg/m2); Massachusetts | Pregnant women with overweight or obesity (BMI 25–40 kg/m2); California | |
Topic | Efficacy trial of adding mindfulness training to a weight loss program | Non-inferiority trial of an online social network-delivered versus clinic-delivered weight loss program | Efficacy trial of a lifestyle program to prevent excess gestational weight gain |
Trial design | 2 groups, randomized | 2 groups, randomized | 2 groups, randomized |
Trial conditions | |||
Intervention condition | Mindfulness | Get social | Getting in balance |
Intervention description | Group sessions (16) with mindfulness content, delivered in person: 12 weekly, 3 bimonthly, and 1 monthly sessiosns over 5.5 months, including an all-day retreat | Group modules (23a) delivered online via private Twitter group: 16 weekly, 4 biweekly, and 6 monthly sessions over 12 months | Individual sessions (13) delivered weekly via telephone (11 sessions) and in person (2 sessions) over ≈3.5 months during pregnancy |
Control condition | Active control | Traditional | Usual care |
Control description | Group sessions (16) with no mindfulness content, delivered in person: 12 weekly, 3 bimonthly, and 1 monthly sessions over 5.5 months, including an all-day retreat | Group sessions (22) delivered in person: 16 weekly, 4 biweekly, and 6 monthly sessions over 12 months | Usual care (no sessions) |
Assessment visits | 3, 6, 9 and 18 months | 6 and 12 months | 32 weeks gestation, 6 and 12 months postpartum |
Orientation session characteristics | |||
Format | In person, with PowerPoint slides | Via webinar, with PowerPoint slides | By telephone conference calls, with PowerPoint slides sent in advance |
Facilitator | Study project director | Postdoctoral fellow or research assistant | Study co-investigator or project manager |
Typical group size | 8–20 participants | 8–15 participants | 1–3 participants |
Length | 90 minutes | 60 minutes | 45 minutes |
Sessions 22 and 23 collapsed for comparability in analyses across conditions.
SHINE, Supporting Health by Integrating Nutrition and Exercise; GLOW, GestationaL Weight Gain and Optimal Wellness.
The first trial, Supporting Health by Integrating Nutrition and Exercise (SHINE) was an efficacy trial testing the addition of mindfulness training to a diet–exercise weight loss program (data collected in 2009–2013, n=194).16 The 16-session mindfulness-based training weight loss program (Mindfulness) was compared against an active control program of behavioral weight loss with identical diet–exercise guidelines (Active Control), with follow-up assessments at 6 and 18 months post-randomization.
The second trial, Get Social, was a non-inferiority trial of an online social network–delivered weight loss program (data collected in 2016–2020, n=217).17 The 23-module Twitter-based program (Get Social) was compared against a 22-session in-person, group-based program (Traditional), with follow-up assessments at 6 and 12 months post-randomization. Get Social Modules 22 and 23 were collapsed for comparability across conditions in analyses. The sample in the present analysis included participants randomized in the first 6 waves while the study was administered at the University of Massachusetts Medical School, before it was moved to the University of Connecticut. The 3 final waves of participants were excluded to reduce potential confounding by participant characteristics and other factors influencing participant engagement at a new institution.
The third trial, GestationaL Weight Gain and Optimal Wellness (GLOW) was an efficacy trial of a 13-session lifestyle program primarily delivered by telephone to prevent excess gestational weight gain (Getting in Balance), which was compared with usual medical care (data collected in 2014–2018, n=389).18,19 Pregnant women were randomized into the trial at 8–15 weeks gestation, with follow-up assessments at 32 weeks gestation, 6 months postpartum, and 12 months postpartum. Here, the GLOW sample excluded 9 women who experienced pregnancy loss before the first follow-up assessment, and thus were ineligible for remaining assessments.
All 3 trials were approved by IRBs and obtained participants’ informed consent in accordance with their institution’s ethical standards.
Implementation of MMI Approach
Each trial moved to implement the MMI approach of prerequisite orientations in response to early concerns about suboptimal or differential participant engagement, and adapted the approach for their unique context (Table 1). Participants here are defined as either before (enrolled before prerequisite orientations were added) or after (enrolled after the prerequisite orientations were added), and by definition cannot be both. SHINE initiated in-person, group-based prerequisite orientations in response to suboptimal and differential retention at follow-up assessments (43.8% [n=85/194] of participants enrolled before prerequisite orientations were added). Get Social initiated interactive group webinar-based prerequisite orientations in response to suboptimal and differential attendance, including early indications that some participants did not attend any of the in-person, group-based intervention sessions (Traditional) (34.6% [n=75/217] of University of Massachusetts Medical School participants before prerequisite orientations were added). Although GLOW retention at follow-up assessments initially appeared high overall, GLOW initiated orientations via telephone conference calls in response to small differences in retention between trial conditions and to enhance attendance (41.1% [n=160/389] of participants before prerequisite orientations were added).
Measures
Trial retention at assessments is presented by trial condition for each primary outcome assessment (e.g., 6-month and 12-month follow-up assessments), before and after adding prerequisite orientation sessions to the trial protocol. A participant was considered retained if body weight was obtained at the primary outcome assessment.
Attendance at intervention sessions is presented by trial condition, before and after adding prerequisite orientations to the trial protocol. Three metrics are presented: mean percentage of sessions attended, percentage of participants who attended 0 sessions, and percentage of participants who attended ≥80% sessions. For SHINE, attendance was defined as participating in an in-person session. For Get Social, attendance was defined as exposure to an intervention module; that is, either attending an in-person, group-based session (Traditional) or by posting, replying, or liking a tweet during the same time period (Get Social). For GLOW, attendance was defined as participating in an individual intervention session (most conducted by telephone). As the GLOW intervention was compared with a usual care control group, there are no attendance data for the control condition.
Statistical Analysis
The impact of adding prerequisite orientations to trial protocols on retention and attendance was tested with multivariate models using estimation via generalized estimating equations. Regression models accounted for within–intervention group correlations where applicable (SHINE and Get Social) and within-person correlation among repeated measurements for valid estimation of treatment effects and associated SEs. Analyses examined if changes in retention and attendance before and after adding prerequisite orientations varied by trial condition using an interaction term (Model 1). If the interaction term was not statistically significant, a second model (Model 2) was conducted with the main effects.
For retention, the percentage of participants with available weight at primary outcome assessments was modeled with log-binomial regression. Given that approximately 10% of participants in Get Social provided a self-reported weight and were considered retained in the original trial, a sensitivity analysis was conducted for retention models that included and excluded participants with self-reported weights. There was no difference in outcomes between models (data not shown) and thus the model with all obtained weight data is presented here.
For attendance, mean attendance (continuous) was modeled with linear mixed effects, and the percentage of participants who attended 0 sessions and who attended ≥80% of sessions were modeled with log-binomial regression. To avoid estimation issues with zero-counts, simple Laplace smoothing was used by adding a pseudocount for models of attendance at 0 sessions.20
Two sets of exploratory analyses were conducted for each of the 3 trials. First, to examine whether adding prerequisite orientations affected the proportion of eligible participants randomized, chi-square tests were used.
Second, to examine whether adding prerequisite orientations affected 5 key demographic characteristics of randomized participants, t-tests were used for the continuous variable (age), and chi-square tests for categorical variables (gender, education [4-year degree and above versus others], and race/ethnicity [non-Hispanic White versus others]). A priori criteria were set to evaluate if a difference for each demographic characteristic was substantively large enough to raise concerns: >5-year difference in mean age and >10% difference in percentage non-White, percentage who completed a 4-year degree, percentage female (where applicable), and percentage with BMI >30 kg/m2 (where applicable; pre-pregnancy weight for GLOW). To adjust for multiple comparisons across the 5 demographic characteristics, a Bonferroni correction of p<0.05/5 = 0.01 was used.
All models assumed p<0.05 for statistical significance unless otherwise noted. Models were run in SAS, version 9.4 or and Stata, version 16.
RESULTS
To orient readers to the trial results (Table 3), unadjusted estimates of retention and attendance before and after adding prerequisite orientations and by trial condition are in Columns 2–8 and adjusted estimates of retention and attendance from the regression models examining the main effects of adding prerequisite orientations and by trial condition (i.e., Model 2) are in Columns 9–11. The impact of adding orientations did not differ by trial condition (Model 1 interaction term, all p> 0.05), except for Get Social attendance at 0 sessions; thus, for parsimony, Model 1 results are available upon request.
Table 3.
Trial Retention and Intervention Session Attendance Before and After Adding Prerequisite Orientations Sessions to Screening Protocols
Variables | Unadjusted estimates | Estimates, regression model 2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Beforea (no orientation sessions) | Afterb (orientation sessions) | Differencec (after-before) | Beforea (no orientation sessions) | Afterb (orientation sessions) | Differencec (after-before) | |||||
Unadjusted estimate | Unadjusted estimate | Unadjusted estimate (95% CI) | Unadjusted estimate | Unadjusted estimate | Unadjusted estimate (95% CI) | Unadjusted difference (95% CI) | Adjusted estimate (95% CI) | Adjusted estimate (95% CI) | Adjusted difference (95% CI) | |
Trial condition | All befored | Trial condition | All aftere | All total | All total | |||||
Control | Intervention | Control | Intervention | |||||||
Retention | ||||||||||
SHINE | Active control | Mindfulness | − | Active control | Mindfulness | − | − | − | − | − |
Sample size, n | 41 | 44 | 85 | 53 | 56 | 109 | 194 | 85 | 109 | 194 |
% weighed at 6 months | 63.4% | 77.3% | − | 86.8% | 89.3% | − | − | − | − | − |
% weighed at 18 months | 58.5% | 75.0% | − | 81.1% | 85.7% | − | − | − | − | − |
% weighed, collapsed | − | − | 76.5% (67.5, 85.5) | − | − | 88.1% (82.0, 94.2) | 11.6% (0.7, 22.5) | 68.8%f (59.0, 78.6) | 86.1%g (79.6, 92.6) | 17.3%h (5.5, 29.1) |
Get Social | Traditional | Get social | − | Traditional | Get social | − | − | − | − | − |
Sample size, n | 36 | 39 | 75 | 71 | 71 | 142 | 217 | 75 | 142 | 217 |
% weight obtained at 6 months | 80.6% | 82.1% | − | 94.4% | 91.6% | − | − | − | − | − |
% weight obtained at 12 months | 77.8% | 89.7% | − | 94.4% | 95.8% | − | − | − | − | − |
% weight obtained, collapsed | − | − | 82.7% (74.1, 91.3) | − | − | 94.0% (90.1, 97.9) | 11.3% (1.9, 20.7) | 82.7%f (74.1, 91.3) | 94.1%g (90.3, 97.9) | 11.4%h (2.0, 20.8) |
GLOW | Usual care | Getting in balance | − | Usual care | Getting in balance | − | − | − | − | − |
Sample size, n | 79 | 81 | 160 | 115 | 114 | 229 | 389 | 160 | 229 | 389 |
% assessed at 32 weeks’ gestation | 94.9% | 87.7% | − | 96.5% | 93.9% | − | − | − | − | − |
% assessed at 6 months postpartum | 96.2% | 86.4% | − | 96.5% | 94.7% | − | − | − | − | − |
% assessed at 12 months postpartum | 97.5% | 85.2% | − | 94.8% | 94.7% | − | − | − | − | − |
% assessed, collapsed | − | − | 94.4% (89.6, 97.4) | − | − | 97.4% (94.4, 99.0) | 3.0% (−1.0, 8.1) | 91.9%f (87.1, 95.5) | 95.6%g (92.9, 98.3) | 3.7%h (−1.3, 8.7) |
Attendance | ||||||||||
SHINE | Active control | Mindfulness | − | Active control | Mindfulness | − | − | − | − | − |
Sample size, n | 41 | 44 | 85 | 53 | 56 | 109 | 194 | 85 | 109 | 194 |
Total number of sessions | 17 | 17 | − | 17 | 17 | − | − | − | − | − |
Mean % of sessions attended | 75.3% | 71.5% | 73.4% (68.2, 78.6) | 77.9% | 77.2% | 77.5% (73.0, 82.1) | 4.2% (−2.6, 11.0) | 73.4%i (68.3, 78.5) | 77.6%j (73.0, 82.1) | 4.2%k (−2.7, 11.0) |
% attended 0% of sessions | 0.0% | 0.0% | 0.0% (0.0, 0.2) | 1.9% | 0.0% | 0.9% (0.0, 2.7) | 0.9% (−0.9, 2.7) | N/A | N/A | N/A |
% attended >80% of sessions | 58.5% | 52.2% | 55.3% (44.7, 65.9) | 66.0% | 60.7% | 63.3% (54.3, 72.4) | 8.0% (−5.9, 21.9) | 55.4%f (44.8, 66.0) | 63.4%g (54.4, 72.4) | 8.0%h (−5.9, 21.9) |
Get Social | Traditional | Get social | − | Traditional | Get social | − | − | − | − | − |
Sample size, n | 36 | 39 | 75 | 71 | 71 | 142 | 217 | 75 | 142 | 217 |
Total number of sessions | 22 | 22 | − | 22 | 22 | − | − | − | − | − |
Mean % of sessions attended | 38.9% | 69.0% | 54.5% (46.0, 63.1) | 56.7% | 69.8% | 63.2% (57.9, 68.5) | 8.7% (−0.8, 18.2) | 54.2%i (46.8, 61.6) | 63.2%j (57.8, 68.6) | 9.1%k (−0.1, 18.2) |
% attended 0% of sessions | 33.3% | 0.0% | 16.0% (7.5, 24.5) | 7.0% | 2.8% | 4.9% (1.3, 8.5) | −11.1% (−20.3, −1.9) | 14.6%f,l (7.1, 22.1) | 4.5%g,l (0.6, 8.4) | −10.1%h,l (−18.6, −1.6) |
% attended >80% of sessions | 13.9% | 48.7% | 32.0% (21.2, 42.8) | 26.8% | 52.1% | 39.4% (31.3, 47.6) | 7.4% (−6.0, 20.9) | 29.8%f (20.1, 39.5) | 38.4%g (30.4, 46.4) | 8.6%h (−4.0, 21.2) |
GLOW | Usual care | Getting in balance | − | Usual care | Getting in balance | − | − | − | − | − |
Sample size, n | N/A | 81 | − | N/A | 114 | − | 81 | 114 | 195 | 195 |
Total number of sessions | − | 13 | − | − | 13 | − | − | − | − | − |
Mean % of sessions attended | − | 82.2% | − | − | 91.0% | − | 8.8% (−0.03, 17.6) | 82.2%i (76.0, 88.5) | 91.0%j (85.7, 96.3) | 8.8%k (0.6, 17.0) |
% attended | − | N/A | - | - | N/A | N/A | N/A | N/A | N/A | N/A |
0% of sessions | ||||||||||
% attended >80% of sessions | − | 79.0% | − | − | 88.6% | − | 9.6% (−0.9, 21.0) | 79.0%f (70.1, 87.9) | 88.6%g (82.8, 94.4) | 9.6%h (−1.0, 20.2) |
Notes: Boldface indicates statistical significance (p<0.05).
Participants enrolled before prerequisite orientations were added to trial.
Participants enrolled after prerequisite orientations were added to trial.
Difference between before and after prerequisite orientations were added to trial, collapsed across trial conditions and assessment visits.
Unadjusted estimate for all participants enrolled before prerequisite orientations were added to trial, collapsed across trial conditions and assessment visits.
Unadjusted estimate for all participants enrolled after prerequisite orientations were added to trial, collapsed across trial condition and assessment visit.
Adjusted estimated proportion for all participants enrolled before prerequisite orientations were added to trial (multiplied by 100%) from logistic regression Model 2.
Adjusted estimated proportion for all participants enrolled after prerequisite orientations were added to trial (multiplied by 100%) from logistic regression Model 2.
Difference between adjusted estimated proportions before and after prerequisite orientations were added to trial, collapsed across trial condition and assessment visit.
Adjusted estimated proportion for all participants enrolled before prerequisite orientations were added to trial, from linear regression Model 2
Adjusted estimated proportion for all participants enrolled after prerequisite orientations were added to trial, from linear regression Model 2.
Difference between adjusted estimates before and after prerequisite orientations were added to trial, collapsed across trial condition and assessment visit, from linear regression Model 2.
Analyses comparing participants who attended 0% of sessions used simple Laplace smoothing (see Methods for details).
SHINE, Supporting Health by Integrating Nutrition and Exercise; GLOW, Gestational Weight Gain and Optimal Wellness.
After adding prerequisite orientations, all 3 trials attained higher participant engagement for trial retention or intervention attendance.
Trial retention at follow-up assessments was higher after adding prerequisite orientations in 2 trials (Table 3, adjusted estimates of differences, highlighted far right column): 17.3% (95% CI=5.5, 29.1) in SHINE and 11.4% (95% CI=2.0, 20.8) in Get Social.
Mean percentage attendance at intervention sessions was higher after adding prerequisite orientations in 1 trial (Table 3, adjusted estimates of differences, highlighted far right column): 8.8% (95% CI=0.6, 17.0) in GLOW.
In 1 trial, fewer participants attended 0 intervention sessions after adding prerequisite orientations: −10.1% (95% CI= −18.6, −1.6) in Get Social; SHINE and GLOW models did not converge owing to the low frequency of attending 0 sessions. In Get Social, there was also a greater decrease in attendance at 0 sessions in the Traditional (control) group than in the Get Social (intervention) group after adding prerequisite orientations (Model 1). Across the 3 trials, there was no change in attendance at ≥80% of intervention sessions after adding prerequisite orientations.
In all trials, after adding prerequisite orientations, there were no changes in the proportion of eligible participants randomized and no differences in demographic characteristics (Table 4). All 95% CIs included 0, even without applying the a priori multiple testing correction. Descriptively, across demographic characteristics, observed differences were inconsistent in direction across trials, and were small, not clinically relevant, and smaller than the a priori difference criteria.
Table 4.
Proportion of Participants Randomized and Demographic Characteristics Before and After Adding Orientations Sessions to Screening Protocols
Demographic characteristics | SHINE (N=194) | Get Social (N=217) | GLOW (N=389) | ||||||
---|---|---|---|---|---|---|---|---|---|
Beforea (no orientation sessions) | Afterb (orientation sessions) | Beforea (no orientation sessions) | Afterb (orientation sessions) | Beforea (no orientation sessions) | Afterb (orientation sessions) | ||||
Mean (SD) or N (%) | Mean (SD) or N (%) | Difference (95% CI) | Mean (SD) or N (%) | Mean (SD) or N (%) | Difference (95% CI) | Mean (SD) or N (%) | Mean (SD) or N (%) | Difference (95% CI) | |
Proportion eligible participants randomized, N randomized/N eligible (%) | 85/93 (91.4%) | 109/125 (87.2%) | −4.2% (−12.4, 4.0) | 75/91 (82.4%) | 142/194 (73.2%) | −9.2% (−19.0, 0.7) | 160/199 (80.4%) | 229/271 (84.5%) | 4.1% (−2.8, 11.4) |
Sample size | 85 | 109 | 75 | 142 | 160 | 229 | |||
Age, years | 45.1 (12.9) | 48.5 (12.4) | 3.4 (−0.2, 7.0) | 44.6 (11.4) | 45.5 (11.0) | 1.0 (−2.2, 4.1) | 32.8 (4.4) | 32.3 (4.1) | −0.5 (−0.4, 1.3) |
Race/ethnicityc | −1.3% (−15.2, 12.6) | 4.2% (−0.4, 8.8) | −2.9% (−12.4, 6.6) | ||||||
White | 51 (60.0%) | 64 (58.7%) | 65 (86.7%) | 129 (90.8%) | 55 (34.4%) | 72 (31.4%) | |||
Non-White | 34 (40.0%) | 45 (41.3%) | 10 (13.3%) | 13 (9.2%) | 105 (65.6%) | 157 (68.6%) | |||
Black/African American | 11 (12.9%) | 15 (13.8%) | 1 (1.3%) | 2 (1.4%) | 14 (8.8%) | 18 (7.8%) | |||
Asian | 10 (11.8%) | 10 (9.2%) | 1 (1.3%) | 0 (0.0%) | 30 (18.8%) | 49 (21.4%) | |||
Hispanic | 9 (10.6%) | 15 (13.8%) | 5 (6.7%) | 7 (4.9%) | 32 (20.0%) | 46 (20.1%) | |||
>1 race/ethnicity; other race | 4 (4.7%) | 5 (4.6%) | 6 (8.0%) | 5 (3.5%) | 29 (18.1%) | 44 (19.2%) | |||
4-year college degree & above | 55 (65.5%) | 70 (64.2%) | −1.3% (−14.8, 12.3) | 49 (65.3%) | 83 (58.5%) | −6.8% (−20.3, 6.7) | 115 (71.9%) | 167 (72.9%) | 1.0% (−8.0, 10.1) |
Female | 72 (84.7%) | 83 (76.2%) | −8.5% (−19.6, 2.5) | 63 (84.0%) | 113 (79.6%) | −4.4% (−15.0, 6.2) | 160 (100%) | 229 (100%) | N/Ad |
BMI ≥30 kg/m2 | 85 (100%) | 109 (100%) | N/Ae | 68 (90.7%) | 122 (85.9%) | −4.8 (−13.5, 3.9) | 59 (36.9%) | 80 (34.9%) | −1.9% (−11.6, 7.8) |
Notes: Boldface indicates statistical significance (p<0.05).
Participants enrolled before prerequisite orientations were added to trial.
Participants enrolled after prerequisite orientations were added to trial.
Difference and CIs for change in % White.
GLOW enrolled a sample of 100% pregnant women.
SHINE enrolled a sample of 100% participants with BMI >30 kg/m2.
SHINE, Supporting Health by Integrating Nutrition and Exercise; GLOW, Gestational Weight Gain and Optimal Wellness.
DISCUSSION
Across 3 trials with early signs of suboptimal and/or differential participant engagement, there was higher trial retention and intervention attendance after adding prerequisite orientation sessions. Each trial creatively and effectively adapted the MMI approach, such as the original in-person prerequisite orientations1 to their specific needs. For instance, Get Social delivered orientations via interactive webinars and facilitated the pro/con discussions via webchat,17 whereas GLOW delivered orientations via telephone conference calls. Importantly, across the 3 trials, there were no changes in the proportion of eligible participants randomized or substantive differences in demographic characteristics after adding prerequisite orientations.
The current analyses are consistent with a recent pragmatic intervention trial for chronic pain patients that implemented the MMI approach of prerequisite orientations after early suboptimal patient engagement.13 Trial retention and attendance were higher for chronic pain patients after adding orientations, despite pain-related challenges for patients leaving their homes for in-person orientations and classes. Although substantially fewer eligible patients enrolled in the pragmatic trial, perhaps owing to adding a prerequisite orientation requirement to the enrollment process, researchers in the pragmatic trial offered that a parallel change in the health system’s policy for access to pain medications, external to the pragmatic trial, could have substantially lowered enrollment.13
Details about the 4 core constructs, key strategies, originally implemented procedures, and subsequent adaptations of the MMI approach are in Table 1. A critical consideration for investigators is to determine which comparison to present when discussing pros/cons. This discussion is likely to be most effective if potential participants are explicitly confronted with the most difficult comparison they will encounter during enrollment, such as whether to participate in a trial with considerable participant burden due to complex trial assessments or relative attractiveness between trial conditions. For instance, in Get Social, the key comparison for young adults to consider was between a Twitter-based program or a standard, in-person, group-based intervention.17 Given comparisons are made explicit, investigators need to thoughtfully select a control condition as well as transparently provide the scientific rationale for such conditions during orientations.21
When adapting and implementing prerequisite orientations for future trials, 3 sets of factors should be considered: logistical (research design and delivery, trial setting, and geographic region), participant (demographics or other participant characteristics likely to impact trial enrollment such as health status), and administrative (staff resources). However, across the trials here, upfront investment of staff resources was related to higher participant engagement. Given orientations can conveniently leverage innovative formats such as webinars or conference calls, orientations may efficiently reduce overall staff time and be cost effective.
The full impact of the MMI approach remains to be experimentally tested. Three potential avenues exist. One avenue could experimentally test specific MMI strategies rather than the entire approach. 22,23 For example, in online experiments informed by MMI, individuals who read an easy-to-understand, visually powerful, 1-page infographic letter illustrating the detrimental impact of dropouts on trial conclusions had substantially greater research literacy and participant trust in the research team relative to individuals reading a control letter.22 A second avenue could leverage optimization trial designs such as the Multiphase Optimization Strategy (MOST) framework24 to identify which core MMI constructs and key strategies—or which combinations of these best enhance participant engagement. A third avenue could embed experiments testing the efficacy of MMI core constructs and key strategies25,26 within large randomized parent trials, similar to embedded recruitment experiments.27 Embedded experiments could assess potential mediators such as participant trust in the research team as mentioned above or other posited measures in the broader retention literature, such as whether individuals feel respected and sufficiently informed about the trial procedures.28
Limitations
Several study limitations exist. One was the reliance on a convenience sample of 3 trials that explicitly chose to add prerequisite orientations to their protocols in response to early suboptimal participant engagement. Though limiting in scope, this sample accessed granular trajectories of trial data (i.e., retention and adherence by cohort before and after implementing orientations), strengthening the analytic design. As more trials make data publicly available, additional trajectory analyses, including specific adjustments to improve these outcomes, will be possible.
A second limitation was the relatively small cell sizes for comparisons by trial condition and by prerequisite orientations, the latter in part because the 3 trials indeed moved quickly to respond to early suboptimal engagement. Yet, descriptively, all retention and attendance outcomes across all 3 trials were in the expected and higher direction, including modest-to-large, albeit non-significant, increases. Given the consistent pattern across outcomes, it is important to ensure not only uniform fidelity for trial interventions, but also fidelity for prerequisite orientations, and may be especially critical for smaller randomized trials.29,30
A third limitation was that the pre–post analytic design limited a causal determination. Indeed, implementing the prerequisite orientations in response to early signs of suboptimal engagement could have been accompanied by co-occurring adjustments to trial procedures. Yet, these adjustments may not be cofounding effects. Rather, the MMI approach provides a structure for open communication and actively listening of participants, thus providing investigators the opportunity to make proactive and responsive adjustments to ensure participant barriers are addressed quickly (e.g., schedule changes or parking stipends).
A fourth limitation is that the MMI approach could conceivably limit sample generalizability for trials by screening out less committed potential participants prior to randomization.31 Yet, there were no consistent or clinically relevant differences in the proportion of eligible participants enrolled or in demographic characteristics after adding orientations. Future research can examine additional baseline characteristics moderating the impact of the MMI approach, including lack of motivation to change the target behaviors or enrollment commitment. Alternatively, the MMI approach could intriguingly be applied to enhance trial generalizability by deeply engaging diverse and traditionally underserved populations, and proactively supporting participant buy-in to the scientific rationale of the trial with a transparent and comprehensive view of the commitment involved in trial participation well before enrolling.
Current study strengths included trials across 3 different intervention delivery channels (in person, social media, telephone) and 3 innovative adaptations to orientation format (in person, webinar/webchat, conference calls). Additionally, participant samples across trials were diverse in age and race/ethnicity.
CONCLUSIONS
The MMI approach, which integrates prerequisite orientation sessions, shows promise for increasing the rigor of trials by improving retention at follow-up assessments and intervention attendance. The MMI approach is readily adaptable to innovative in-person, webinar/webchat, and conference call formats. Future experimental research, embedded within ongoing parent trials, can strengthen the evidence base by examining MMI effects on retention, attendance, and generalizability of trial samples, and participant trust in the research enterprise.
ACKNOWLEDGMENTS
The research presented in this paper is that of the authors and does not reflect the official policy of NIH. An early version of these data was presented in a symposium at the 2018 Society of Behavioral Medicine Annual Meeting (Jake-Schoffman DE, Farias R, Leahey T, Brown SD, Baskin ML. Innovative techniques to enhance engagement and retention in RCTs: Moving towards evidence-based procedures. Ann Behav Med. 2018;52:S387-S387). Funding for the original 3 trials and current analysis was provided by NIH P01 AT00501 (Multiple Principal Investigator [PI]: Hecht/Epel); NIH K24AT007827 (PI: Hecht), NIH K01AT004199 (PI: Daubenmier), National Center for Advancing Translational Sciences, UCSF-CTSI UL1 TR000004 (PI: Hecht), NIH R01DK103944 (PI: Pagoto), NIH K24 HL124366 (PI: Pagoto), NIH R01 HD073572 (PI: Ferrara), NIH R03 DK113325 (PI: Brown), NIH R01 HL128666 (PI: Kiernan), and a Stanford Cancer Institute Cancer Innovation Award (PI: Kiernan). The Stanford Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center. Dr. Kiernan was a Consultant on the SHINE trial for her contributions regarding the orientation sessions. No other financial disclosures were reported by the authors of this paper.
The study sponsors had no role in the study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit this report for publication.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
REFERENCES
- 1.Goldberg JH, Kiernan M. Innovative techniques to address retention in a behavioral weight-loss trial. Health Educ Res. 2005;20(4):439–447. 10.1093/her/cyg139. [DOI] [PubMed] [Google Scholar]
- 2.Kiernan M, Brown SD, Schoffman DE, et al. Promoting healthy weight with ―stability skills first‖: a randomized trial. J Consult Clin Psychol. 2013;81(2):336–346. 10.1037/a0030544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Spring B, Pfammatter AF, Marchese SH, et al. A factorial experiment to optimize remotely delivered behavioral treatment for obesity: results of the Opt-IN study. Obesity (Silver Spring). 2020;28(9):1652–1662. 10.1002/oby.22915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Spring B, Schneider K, McFadden H, et al. Multiple behavior changes in diet and activity: a randomized controlled trial using mobile technology. Arch Intern Med. 2012;172(10):789–796. 10.1001/archinternmed.2012.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jake-Schoffman DE, Turner-McGrievy G, Wilcox S, Moore JB, Hussey JR, Kaczynski AT. The mFIT (Motivating Families with Interactive Technology) Study: a randomized pilot to promote physical activity and healthy eating through mobile technology. J Technol Behav Sci. 2018;3(3):179–189. 10.1007/s41347-018-0052-8. [DOI] [Google Scholar]
- 6.Standiford DA, Morwessel N, Bishop FK, et al. Two-step recruitment process optimizes retention in FLEX clinical trial. Contemp Clin Trials Commun. 2018;12:68–75. 10.1016/j.conctc.2018.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Xiao L, Lv N, Rosas LG, et al. Use of a motivational interviewing-informed strategy in group orientations to improve retention and intervention attendance in a randomized controlled trial. Health Educ Res. 2016;31(6):729–737. 10.1093/her/cyw048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hippolyte JM, Phillips-Caesar EG, Winston GJ, Charlson ME, Peterson JC. Recruitment and retention techniques for developing faith-based research partnerships, New York City, 2009−2012. Prev Chronic Dis. 2013;10:120142. 10.5888/pcd10.120142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.King AC, Campero I, Sheats JL, et al. Testing the effectiveness of physical activity advice delivered via text messaging vs. human phone advisors in a Latino population: the On The Move randomized controlled trial design and methods. Contemp Clin Trials. 2020;95:106084. 10.1016/j.cct.2020.106084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pebole M, Gobin RL, Hall KS. Trauma-informed exercise for women survivors of sexual violence. Transl Behav Med. 2021;11(2):686–691.. 10.1093/tbm/ibaa043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Puterman E, Weiss J, Lin J, et al. Aerobic exercise lengthens telomeres and reduces stress in family caregivers: a randomized controlled trial − Curt Richter Award Paper 2018. Psychoneuroendocrinology. 2018;98:245–252. 10.1016/j.psyneuen.2018.08.002. [DOI] [PubMed] [Google Scholar]
- 12.Felder JN, Epel ES, Neuhaus J, Krystal AD, Prather AA. Efficacy of digital cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a randomized clinical trial. JAMA Psychiatry. 2020;77(5):484–492. 10.1001/jamapsychiatry.2019.4491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mayhew M, Leo MC, Vollmer WM, DeBar LL, Kiernan M. Interactive group-based orientation sessions: a method to improve adherence and retention in pragmatic clinical trials. Contemp Clin Trials Commun. 2020;17:100527. 10.1016/j.conctc.2020.100527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Northrup TF, Greer TL, Walker R, et al. An ounce of prevention: a pre-randomization protocol to improve retention in substance use disorder clinical trials. Addict Behav. 2017;64:137–142. 10.1016/j.addbeh.2016.08.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173–202. 10.1146/annurev.publhealth.19.1.173. [DOI] [PubMed] [Google Scholar]
- 16.Daubenmier J, Moran PJ, Kristeller J, et al. Effects of a mindfulness-based weight loss intervention in adults with obesity: a randomized clinical trial. Obesity (Silver Spring). 2016;24(4):794–804. 10.1002/oby.21396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang ML, Waring ME, Jake-Schoffman DE, et al. Clinic versus online social network-delivered lifestyle interventions: protocol for the Get Social noninferiority randomized controlled trial. JMIR Res Protoc. 2017;6(12):e243. 10.2196/resprot.8068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Brown SD, Hedderson MM, Ehrlich SF, et al. Gestational weight gain and optimal wellness (GLOW): rationale and methods for a randomized controlled trial of a lifestyle intervention among pregnant women with overweight or obesity. BMC Pregnancy Childbirth. 2019;19(1):145. 10.1186/s12884-019-2293-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ferrara A, Hedderson MM, Brown SD, et al. A telehealth lifestyle intervention to reduce excess gestational weight gain in pregnant women with overweight or obesity (GLOW): a randomised, parallel-group, controlled trial. Lancet Diabetes Endocrinol. 2020;8(6):490–500. 10.1016/s2213-8587(20)30107-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Casella G, Berger RL. Statistical Inference. 2nd ed. Pacific Grove, CA: Duxbury; 2002. [Google Scholar]
- 21.Freedland KE, King AC, Ambrosius WT, et al. The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel. J Clin Epidemiol. 2019;110:74–81. 10.1016/j.jclinepi.2019.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kiernan M, Oppezzo MA, Resnicow K, Alexander GL. Effects of a methodological infographic on research participants’ knowledge, transparency, and trust. Health Psychol. 2018;37(8):782–786. 10.1037/hea0000631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Brown SD, Lee K, Schoffman DE, King AC, Crawley LM, Kiernan M. Minority recruitment into clinical trials: experimental findings and practical implications. Contemp Clin Trials. 2012;33(4):620–623. 10.1016/j.cct.2012.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Collins LM, Murphy SA, Strecher V. The Multiphase Optimization Strategy (MOST) and the Sequential Multiple Assignment Randomized Trial (SMART): new methods for more potent eHealth interventions. Am J Prev Med. 2007;32(5 Suppl):S112–S118. 10.1016/j.amepre.2007.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Fitzpatrick SL, Jeffery R, Johnson KC, et al. Baseline predictors of missed visits in the Look AHEAD study. Obesity (Silver Spring). 2014;22(1):131–140. 10.1002/oby.20613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ritchie ND, Kaufmann PG, Gritz RM, Sauder KA, Holtrop JS. Presessions to the National Diabetes Prevention Program may be a promising strategy to improve attendance and weight loss outcomes. Am J Health Promot. 2019;33(2):289–292. 10.1177/0890117118786195. [DOI] [PubMed] [Google Scholar]
- 27.Rick J, Graffy J, Knapp P, et al. Systematic techniques for assisting recruitment to trials (START): study protocol for embedded, randomized controlled trials. Trials. 2014;15:407. 10.1186/1745-6215-15-407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kost RG, Lee LM, Yessis J, Coller BS, Henderson DK. Assessing research participants’ perceptions of their clinical research experiences. Clin Transl Sci. 2011;4(6):403–413. 10.1111/j.1752-8062.2011.00349.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443–451. 10.1037/0278-6133.23.5.443. [DOI] [PubMed] [Google Scholar]
- 30.Borrelli B, Sepinwall D, Ernst D, et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult and Clin Psychol. 2005;73(5):852–860. 10.1037/0022-006x.73.5.852. [DOI] [PubMed] [Google Scholar]
- 31.Powell LH, Freedland KE, Kauffman PG. Behavioral Clinical Trials for Chronic Diseases. 1st ed. Basel, Switzerland: Springer International Publishing; 2020. 10.1007/978-3-030-39330-4. [DOI] [Google Scholar]